Melt Granulation Techniques as an Alternative Manufacturing Technology for the Generic Development of Apixaban 5 mg Immediate-Release Tablets: A Case Study

S. Jailani,Prajakta Pathare,Sakshi Kunjir,Kishor Chakraborty,C. K. Dhanapal,Noohu Abdulla Khan,Rajkumar Malayandi
DOI: https://doi.org/10.1007/s12247-024-09876-0
2024-10-26
Journal of Pharmaceutical Innovation
Abstract:Apixaban (APX) is a poorly soluble drug; hence, a micronized active pharmaceutical ingredient (API) is widely used for manufacturing immediate-release (IR) tablets using the dry granulation method (DG). Melt granulation techniques (MGTS) are widely used for enhancing solubility by reducing the crystallinity and/or formation of in situ amorphous forms. The present investigation aims to manufacture APX IR tablets with non-micronized API by MGTS and compare the same with tablets using micronized API manufactured by DG.
pharmacology & pharmacy
What problem does this paper attempt to address?